Rumors have been swirling that Amazon might try to break into the pharmacy business. On Monday, CNBC reported that Amazon (AMZN) has put its plans to sell and distribute pharmaceutical products on hold. An Amazon representative told CNNMoney that the company does not comment on rumors or speculation.

A fleet of major coffee brands is gearing up for a long haul fight against California’s coffee warnings. The companies say that the trace amounts of acrylamide — a cancer-causing chemical — found in coffee do not warrant a label, according to the Wall Street Journal.

A study by the Urban Institute says the average monthly premium for healthcare insurance in Nevada increased 45.6 percent this year.

The state’s health exchange under the Affordable Care Act is moving off the federal platform for signing up for insurance, relying on lessons learned in the past and in other states.

The CMS issued a 523-page final rule late Monday that agency officials said is meant to give states more power to regulate their individual and small-group health insurance markets. The rule also furthers the Trump administration's agenda of chipping away at Affordable Care Act rules in lieu of a full repeal, which congressional Republicans haven't been able to pull off.

Many top drugmakers reaped savings from U.S. tax reform, which lawmakers touted as a boon that would deliver jobs and other benefits. In pharma, tax savings and cash brought home from abroad could have lowered costs for patients—or so one senator's reasoning goes.